SUMO: a regulator of gene expression and genome integrity
暂无分享,去创建一个
[1] Y. Kuryshev,et al. Increased K+ Efflux and Apoptosis Induced by the Potassium Channel Modulatory Protein KChAP/PIAS3β in Prostate Cancer Cells* , 2002, The Journal of Biological Chemistry.
[2] M. Hochstrasser,et al. A new protease required for cell-cycle progression in yeast , 1999, Nature.
[3] H. Saitoh,et al. Enzymes of the SUMO Modification Pathway Localize to Filaments of the Nuclear Pore Complex , 2002, Molecular and Cellular Biology.
[4] F. Melchior,et al. A Small Ubiquitin-Related Polypeptide Involved in Targeting RanGAP1 to Nuclear Pore Complex Protein RanBP2 , 1997, Cell.
[5] G. Nucifora,et al. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[6] H. Yasuda,et al. Yeast Ull1/Siz1 Is a Novel SUMO1/Smt3 Ligase for Septin Components and Functions as an Adaptor between Conjugating Enzyme and Substrates* , 2001, The Journal of Biological Chemistry.
[7] Juliana Xu,et al. Activation of p53 by Protein Inhibitor of Activated Stat1 (PIAS1)* , 2002, The Journal of Biological Chemistry.
[8] F. Melchior,et al. Ubiquitin‐Related Modifier SUMO1 and Nucleocytoplasmic Transport , 2002, Traffic.
[9] R. Derynck,et al. Sumoylation of Smad4, the Common Smad Mediator of Transforming Growth Factor-β Family Signaling* , 2003, Journal of Biological Chemistry.
[10] Xin-Hua Feng,et al. SUMO-1/Ubc9 Promotes Nuclear Accumulation and Metabolic Stability of Tumor Suppressor Smad4* , 2003, Journal of Biological Chemistry.
[11] N. Ellis,et al. Regulation and Localization of the Bloom Syndrome Protein in Response to DNA Damage , 2001, The Journal of cell biology.
[12] Y. Takahashi,et al. A novel factor required for the SUMO1/Smt3 conjugation of yeast septins. , 2001, Gene.
[13] J. Palvimo,et al. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] O. Jänne,et al. The Nuclear Receptor Interaction Domain of GRIP1 Is Modulated by Covalent Attachment of SUMO-1* , 2002, The Journal of Biological Chemistry.
[15] G. E. Davis,et al. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis , 2001, Apoptosis.
[16] L. Latonen,et al. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization , 2003, Journal of Cell Science.
[17] D. Livingston,et al. Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300 , 2003, Science.
[18] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[19] M. Kaghad,et al. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. , 2000, The Journal of biological chemistry.
[20] Christopher D. Lima,et al. Structural Basis for E2-Mediated SUMO Conjugation Revealed by a Complex between Ubiquitin-Conjugating Enzyme Ubc9 and RanGAP1 , 2002, Cell.
[21] V. Orlando. Polycomb, Epigenomes, and Control of Cell Identity , 2003, Cell.
[22] M. Dasso,et al. Association of the Human SUMO-1 Protease SENP2 with the Nuclear Pore* , 2002, The Journal of Biological Chemistry.
[23] R. Honda,et al. Sumoylation of Mdm2 by Protein Inhibitor of Activated STAT (PIAS) and RanBP2 Enzymes* , 2002, The Journal of Biological Chemistry.
[24] H. Yasuda,et al. PIAS1 and PIASxα Function as SUMO-E3 Ligases toward Androgen Receptor and Repress Androgen Receptor-dependent Transcription* , 2002, The Journal of Biological Chemistry.
[25] J. Iñiguez-Lluhí,et al. A Synergy Control Motif within the Attenuator Domain of CCAAT/Enhancer-binding Protein α Inhibits Transcriptional Synergy through Its PIASy-enhanced Modification by SUMO-1 or SUMO-3* , 2003, The Journal of Biological Chemistry.
[26] K. Shuai,et al. Modulation of STAT signaling by STAT-interacting proteins , 2000, Oncogene.
[27] Yongsok Kim,et al. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] Keiji Tanaka,et al. Sterol Regulatory Element-binding Proteins Are Negatively Regulated through SUMO-1 Modification Independent of the Ubiquitin/26 S Proteasome Pathway* , 2003, The Journal of Biological Chemistry.
[29] Miguel Beato,et al. Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.
[30] P. Pelicci,et al. PML interaction with p53 and its role in apoptosis and replicative senescence , 2001, Oncogene.
[31] Y. Taketani,et al. SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin , 2002, Oncogene.
[32] R. Moyzis,et al. Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system. , 1996, Genomics.
[33] R. DePinho,et al. SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities* , 2002, The Journal of Biological Chemistry.
[34] Boris Pfander,et al. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO , 2002, Nature.
[35] K. Horwitz,et al. The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression* , 2002, The Journal of Biological Chemistry.
[36] S. Grossman,et al. Physical and Functional Interactions between PML and MDM2* , 2003, Journal of Biological Chemistry.
[37] N. Perrimon,et al. The Promise and Perils of Wnt Signaling Through β-Catenin , 2002, Science.
[38] H. Saitoh,et al. Perturbation of SUMOlation Enzyme Ubc9 by Distinct Domain within Nucleoporin RanBP2/Nup358* , 2002, The Journal of Biological Chemistry.
[39] S. Müller,et al. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Markus,et al. Covalent Attachment of the SUMO-1 Protein to the Negative Regulatory Domain of the c-Myb Transcription Factor Modifies Its Stability and Transactivation Capacity* , 2002, The Journal of Biological Chemistry.
[41] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[42] E. Milgrom,et al. Sumoylation of the Progesterone Receptor and of the Steroid Receptor Coactivator SRC-1* , 2003, The Journal of Biological Chemistry.
[43] Y. Furuichi,et al. Covalent Modification of the Werner's Syndrome Gene Product with the Ubiquitin-related Protein, SUMO-1* , 2000, The Journal of Biological Chemistry.
[44] A. Dejean,et al. SUMO: of branched proteins and nuclear bodies , 2001, Oncogene.
[45] G. Blobel,et al. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex , 1996, The Journal of cell biology.
[46] A. Dejean,et al. The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity , 2002, Cell.
[47] P. Moitra,et al. Sumoylation of Topoisomerase I Is Involved in Its Partitioning between Nucleoli and Nucleoplasm and Its Clearing from Nucleoli in Response to Camptothecin* , 2002, The Journal of Biological Chemistry.
[48] E. Eaton,et al. Modification of CCAAT/Enhancer-binding Protein-β by the Small Ubiquitin-like Modifier (SUMO) Family Members, SUMO-2 and SUMO-3* , 2003, Journal of Biological Chemistry.
[49] Tetsuya Yamamoto,et al. Regulation of Transforming Growth Factor-β Signaling by Protein Inhibitor of Activated STAT, PIASy through Smad3* , 2003, Journal of Biological Chemistry.
[50] Richard S. Rogers,et al. SUMO Modification of STAT1 and Its Role in PIAS-mediated Inhibition of Gene Activation* , 2003, Journal of Biological Chemistry.
[51] O. Silvennoinen,et al. PIAS proteins promote SUMO-1 conjugation to STAT1. , 2003, Blood.
[52] M. Muratani,et al. How the ubiquitin–proteasome system controls transcription , 2003, Nature Reviews Molecular Cell Biology.
[53] M. Hochstrasser. SP-RING for SUMO New Functions Bloom for a Ubiquitin-like Protein , 2001, Cell.
[54] F. Ruddle,et al. Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxβ , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[55] F. Melchior,et al. Activation of Transforming Growth Factor-β Signaling by SUMO-1 Modification of Tumor Suppressor Smad4/DPC4* , 2003, Journal of Biological Chemistry.
[56] R. Conaway,et al. Emerging Roles of Ubiquitin in Transcription Regulation , 2002, Science.
[57] Erica S. Johnson,et al. An E3-like Factor that Promotes SUMO Conjugation to the Yeast Septins , 2001, Cell.
[58] A. Dejean,et al. The PML nuclear bodies: actors or extras? , 1999, Current opinion in genetics & development.
[59] E. Yeh,et al. Ubiquitin-like proteins: new wines in new bottles. , 2000, Gene.
[60] S. Müller,et al. PIAS/SUMO: new partners in transcriptional regulation , 2003, Cellular and Molecular Life Sciences CMLS.
[61] A. Tyner,et al. Functional analysis and intracellular localization of p53 modified by SUMO-1 , 2001, Oncogene.
[62] O. Jänne,et al. PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases , 2002, Molecular and Cellular Biology.
[63] Fang Liu,et al. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[64] Qian Zhang,et al. Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma1 , 2002, The Journal of Immunology.
[65] A. Baniahmad,et al. The amino terminus of the human AR is target for corepressor action and antihormone agonism. , 2002, Molecular endocrinology.
[66] Jiandong Chen,et al. MDM2-ARF complex regulates p53 sumoylation , 2003, Oncogene.
[67] M. Nakao,et al. Serum response factor is modulated by the SUMO-1 conjugation system. , 2003, Biochemical and biophysical research communications.
[68] Philipp Stelter,et al. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation , 2003, Nature.
[69] E. Yeh,et al. Differential Regulation of Sentrinized Proteins by a Novel Sentrin-specific Protease* , 2000, The Journal of Biological Chemistry.
[70] J. Hoeijmakers. Genome maintenance mechanisms for preventing cancer , 2001, Nature.
[71] D. Michel,et al. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. , 2002, Endocrinology.
[72] M. Kagey,et al. The Polycomb Protein Pc2 Is a SUMO E3 , 2003, Cell.
[73] Pier Paolo Pandolfi,et al. The Promyelocytic Leukemia Protein Protects p53 from Mdm2-mediated Inhibition and Degradation* , 2003, Journal of Biological Chemistry.
[74] M. Nakao,et al. The Aryl Hydrocarbon Receptor Nuclear Transporter Is Modulated by the SUMO-1 Conjugation System* , 2002, The Journal of Biological Chemistry.
[75] Leroy F. Liu,et al. SUMO-1 Conjugation to Human DNA Topoisomerase II Isozymes* , 2000, The Journal of Biological Chemistry.
[76] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.